Estabrook Capital Management - LEXICON PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Estabrook Capital Management ownership history of LEXICON PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$10,900
-52.4%
10,0000.0%0.00%
-50.0%
Q2 2023$22,900
-5.8%
10,0000.0%0.00%0.0%
Q1 2023$24,300
+27.2%
10,0000.0%0.00%
+33.3%
Q4 2022$19,100
-99.9%
10,0000.0%0.00%
-25.0%
Q3 2022$24,000,000
+29.0%
10,0000.0%0.00%
+33.3%
Q2 2022$18,600,000
-11.0%
10,0000.0%0.00%0.0%
Q1 2022$20,900,000
-47.0%
10,0000.0%0.00%
-50.0%
Q4 2021$39,400,00010,0000.01%
Other shareholders
LEXICON PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Ulys, L.L.C. 4,321,214$62,009,000100.00%
Artal Group S.A. 57,517,977$825,383,00017.04%
NEA Management Company, LLC 2,382,286$34,186,0001.77%
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 35,714$512,0001.49%
BRIDGER MANAGEMENT, LLC 1,029,926$14,779,0000.95%
FALCON POINT CAPITAL, LLC 287,809$4,130,0000.71%
HANCOCK WHITNEY CORP 664,025$9,529,0000.40%
KINGDON CAPITAL MANAGEMENT, L.L.C. 494,380$7,094,0000.39%
ELLINGTON MANAGEMENT GROUP LLC 11,700$168,0000.23%
Convergence Investment Partners, LLC 114,157$1,638,0000.22%
View complete list of LEXICON PHARMACEUTICALS INC shareholders